Infliximab (INF) is one of the five tumor necrosis factor-α (TNF) inhibitors that is routinely used for indications of chronic inflammatory diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), ankylosing spondylitis (AS), and psoriatic arthritis (PsA). Here, TNF is linked to ankylosing spondylitis.